Loading organizations...
Key people at 111° West Capital.
111° West Capital is a multi-stage investment firm specializing in commercial-stage enterprise software companies transforming the healthcare sector. The firm employs a distinct, hands-on investment approach, leveraging its specialized team and operator network to drive substantial growth within its portfolio, offering strategic guidance beyond capital.
Co-founded in 2021 by Managing Partner Andrew Brooks, a medical doctor, the firm emerged from a deep understanding of the imperative for technological innovation in healthcare delivery. This foundational insight guides its strategy, identifying and cultivating software solutions addressing critical industry challenges and opportunities.
The firm partners with enterprise software companies developing impactful solutions for the healthcare industry. Its vision centers on catalyzing breakthrough growth for these portfolio companies, ultimately guiding them to successful and strategic exits. This commitment aims to foster significant advancements in healthcare through targeted investment.
111° West Capital is a multi-stage investment firm founded in 2021 that specializes in partnering with enterprise software companies transforming the healthcare sector. The firm focuses primarily on commercial-stage companies within digital health, leveraging a hands-on approach through its investment team and operator network to drive breakthrough growth and successful exits. Their portfolio includes high-growth digital health companies such as Arine, emphasizing innovation in healthcare technology[1][3].
Founded in 2021, 111° West Capital was established to address the growing intersection of enterprise software and healthcare innovation. The firm’s founding partners brought together expertise in venture capital and healthcare technology, evolving their focus to support commercial-stage companies that are poised for significant scale and impact. Since inception, the firm has concentrated on building a network that combines investment acumen with operational support to accelerate growth in digital health[1][3].
111° West Capital rides the trend of digital transformation in healthcare, where enterprise software solutions are increasingly critical for improving patient outcomes, operational efficiency, and data management. The timing aligns with rising healthcare digitization, regulatory support for health tech innovation, and growing demand for scalable healthcare IT solutions. By focusing on commercial-stage companies, the firm positions itself to influence the maturation and scaling of impactful healthcare technologies, contributing to a more efficient and connected healthcare ecosystem[1][3].
Looking ahead, 111° West Capital is likely to deepen its focus on digital health enterprise software, capitalizing on ongoing healthcare digitization trends and increasing adoption of technology-driven care models. The firm’s hands-on approach and operator network will be key assets in helping portfolio companies navigate complex healthcare markets and regulatory environments. As healthcare continues to evolve with AI, telehealth, and data analytics, 111° West Capital’s influence in shaping scalable, innovative solutions is expected to grow, reinforcing its role as a pivotal investor in healthcare technology[1][3].
Key people at 111° West Capital.
111° West Capital has 23 tracked investments across 15 companies. The latest tracked deal is $30.0M Series C in Arine in May 2025.
